strontium has been researched along with Conus Medullaris Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badawi, JK | 1 |
| Tao, H; Wang, M; Wang, Y; Wang, Z; Yu, X | 1 |
| Gebski, V; Gruenewald, S; Spry, N; Turner, SL | 1 |
| Arndt, JW; Hamdy, NA; Lycklama à Nijeholt, GA; Papapoulos, SE; Pelger, RC; Soerdjbalie-Maikoe, V; Zwinderman, AH | 1 |
1 review(s) available for strontium and Conus Medullaris Syndrome
| Article | Year |
|---|---|
[Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
Topics: Bone Density Conservation Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Diphosphonates; Germany; Guideline Adherence; Humans; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Radioisotopes; Radium; Spinal Cord Compression; Spinal Neoplasms; Strontium; Survival Rate; Urologic Neoplasms | 2012 |
2 trial(s) available for strontium and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Clinical significance of zoledronic acid and strontium-89 in patients with asymptomatic bone metastases from non-small-cell lung cancer.
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Spinal Cord Compression; Strontium; Zoledronic Acid | 2013 |
Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer.
Topics: Bone Neoplasms; Diarrhea; Follow-Up Studies; Hematologic Diseases; Humans; Male; Nausea; Neoplasm Metastasis; Pain; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Spinal Cord Compression; Strontium; Strontium Radioisotopes; Surveys and Questionnaires; Treatment Outcome; Vomiting | 2001 |
1 other study(ies) available for strontium and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton.
Topics: Aged; Combined Modality Therapy; Diphosphonates; Humans; Lumbar Vertebrae; Male; Pain; Palliative Care; Prostatic Neoplasms; Retrospective Studies; Spinal Cord Compression; Spinal Neoplasms; Strontium; Thoracic Vertebrae; Treatment Outcome | 2002 |